Jianming M. Ying

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 321 publications

Corrigendum to "CDC34 suppresses macrophage phagocytic activity and predicts poor response to immune checkpoint inhibitor in cancers" [Cancer Lett. 628 (2025) 217822].

Corrigendum to "CDC34 suppresses macrophage phagocytic activity and predicts poor response to immune checkpoint inhibitor in cancers" [Cancer Lett. 628 (2025) 217822].

Journal: Cancer letters

Published: July 22, 2026

Predictive value of 18F-FDG PET-CT for the major pathologic response to neoadjuvant immunotherapy in non-small cell lung cancer

Predictive value of 18F-FDG PET-CT for the major pathologic response to neoadjuvant immunotherapy in non-small cell lung cancer

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: May 18, 2026

Biomarker exploration for immunotherapy plus chemotherapy following resistance to third-generation EGFR-TKIs in lung adenocarcinoma.

Biomarker exploration for immunotherapy plus chemotherapy following resistance to third-generation EGFR-TKIs in lung adenocarcinoma.

Journal: BMC cancer

Published: February 18, 2026

Chinese guidelines for HER2-targeted therapy in gastric and gastroesophageal junction adenocarcinoma (2025 Edition).

Chinese guidelines for HER2-targeted therapy in gastric and gastroesophageal junction adenocarcinoma (2025 Edition).

Journal: Journal of hematology & oncology

Published: February 02, 2026

Subtyping atypical eosinophilic renal cell tumours through integrated morphological, immunohistochemical, and mutational characters.

Subtyping atypical eosinophilic renal cell tumours through integrated morphological, immunohistochemical, and mutational characters.

Journal: BMC cancer

Published: January 24, 2026

Radiological, Molecular, and Pathological Factors Unite: A Model for Predicting Recurrence-Free Survival in Pathological Stage I Lung Adenocarcinoma.

Radiological, Molecular, and Pathological Factors Unite: A Model for Predicting Recurrence-Free Survival in Pathological Stage I Lung Adenocarcinoma.

Journal: Thoracic cancer

Published: January 21, 2026

MMHC-OCPR: Prediction of Platinum Response and Recurrence Risk in Ovarian Cancer with Multimodal Deep Learning.

MMHC-OCPR: Prediction of Platinum Response and Recurrence Risk in Ovarian Cancer with Multimodal Deep Learning.

Journal: Biomedicines

Published: December 22, 2025

Development and validation of a pathomics-driven machine learning model for individualized prediction of neoadjuvant chemotherapy response and early recurrence in HR-positive, HER2-negative breast cancer.

Development and validation of a pathomics-driven machine learning model for individualized prediction of neoadjuvant chemotherapy response and early recurrence in HR-positive, HER2-negative breast cancer.

Journal: Frontiers in oncology

Published: December 17, 2025

RET Fusion-Positive Lung Adenocarcinoma: Partner-Specific Clinicopathological Characteristics, Co-Mutation Profiles, and Implications for Targeted and Immunotherapy.

RET Fusion-Positive Lung Adenocarcinoma: Partner-Specific Clinicopathological Characteristics, Co-Mutation Profiles, and Implications for Targeted and Immunotherapy.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 07, 2025

Germline Mutation Landscape of Neuroendocrine Tumors in the Chinese Population.

Germline Mutation Landscape of Neuroendocrine Tumors in the Chinese Population.

Journal: International journal of cancer

Published: November 04, 2025

Correlation analysis between growth heterogeneity and genetic mutations in resected subsolid lung adenocarcinoma based on long-term computed tomography (CT) follow-up.

Correlation analysis between growth heterogeneity and genetic mutations in resected subsolid lung adenocarcinoma based on long-term computed tomography (CT) follow-up.

Journal: Translational lung cancer research

Published: November 03, 2025

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing.

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing.

Journal: Journal of visualized experiments : JoVE

Published: October 27, 2025

Showing 1-12 of 321

Last Updated: 09/26/2026